EE141 Cost-Effectiveness of Pembrolizumab for Adjuvant Treatment of Patients With Renal-Cell Carcinoma Who Have Undergone Nephrectomy in Colombia
Abstract
Authors
J. Urrego-Reyes Arnedo C Marrugo V Wurcel H Jaramillo G Baluni S Mehta S Gotarkar L Bernal